Tildrakizumab monoclonal antibody drug. Used in treatment of psoriasis. Targets interleukin-23. Generic name and stylized antibody representation.

---

Size: 7030px × 2804px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, autoimmune, biological, biosimilar, biotech, biotechnology, cytokine, disease, drug, il-23, il-23p19, immune, immunoglobulin, immunology, inflammatory, infusion, injection, inn, interleukin, interleukin-23, mab, monoclonal, nomenclature, peptide, protein, psoriasis, system, tildrakizumab